Werewolf Therapeutics (HOWL) Stock Price
Werewolf Therapeutics Price
Revenue at Werewolf Therapeutics has contracted by 23.1% per year over the past 3 years to 1.89 M USD. Werewolf Therapeutics's net margin stands at -3,740.8%, down from -1,199.8% several years earlier. Analysts set a median price target of 4.08 USD, implying 298.0% above the current price. Of 12 analysts, 9 rate the stock a buy — an overall Buy consensus.
Werewolf Therapeutics stock price
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Werewolf Therapeutics business model & stock analysis
Frequently asked questions about Werewolf Therapeutics
6 analysts currently rate the Werewolf Therapeutics stock: 0 recommend buying, 3 holding and 3 selling.
Converted at the current exchange rate, the Werewolf Therapeutics share trades at 0.92 EUR (1.02 USD).
The Werewolf Therapeutics share (HOWL) is listed on 1 stock exchanges, including: NASDAQ (HOWL).
The revenue cannot currently be calculated for Werewolf Therapeutics.
The expected profit of Werewolf Therapeutics is -43.20 M USD. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Werewolf Therapeutics is currently -1.11. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Werewolf Therapeutics stock.
The P/S cannot be calculated for Werewolf Therapeutics currently.
The Eulerpool Quality Score for Werewolf Therapeutics is 2/10.
The ISIN of Werewolf Therapeutics is US95075A1079. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of Werewolf Therapeutics is HOWL. The ticker symbol is used to trade Werewolf Therapeutics shares on the stock exchange.
Werewolf Therapeutics stock
Werewolf Therapeutics Peer Group
Werewolf Therapeutics Ticker
Werewolf Therapeutics FIGI
All fundamentals and in-depth analysis of Werewolf Therapeutics
Our stock analysis for Werewolf Therapeutics stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Werewolf Therapeutics. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.